Existing collection in use without an OMB Control Number
No
Regular
01/22/2021
Requested
Previously Approved
36 Months From Approved
2,007,500
0
3,011,250
0
0
0
The data collected through this ICR
informs the Federal Government's understanding of disease patterns
and furthers the development of policies for prevention and control
of disease spread and impact related to the 2019 Novel Coronavirus
(COVID-19). One of the most important uses of the data collected
through this ICR is to determine critical allocations of limited
supplies (e.g., protective equipment and medication). For instance,
this collection has been used to distribute Remdesivir, a vital
therapeutic that HHS distributes to the American healthcare system,
via distinct data calls on regular intervals. As of July 10, HHS
reduced the number requests for data from hospitals to support
allocations of Remdesivir. HHS has stopped sending out one-time
requests for data to aid in the distribution of Remdesivir or any
other treatments or supplies. This consolidated daily reporting is
the only mechanism used for the distribution calculations, and
daily reports are needed to ensure accurate calculations.
This ICR is being submitted as
“in use without an OMB approval.”
$40,300,000
No
No
No
No
No
No
Yes
Sherette Funn-Coleman
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.